These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34459817)

  • 1. An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis.
    O'Leary S; Bahlool AZ; O'Connor G; Cryan SA; Keane JM; O'Sullivan MP
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34459817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Macrophage Response to
    Maphasa RE; Meyer M; Dube A
    Front Cell Infect Microbiol; 2020; 10():618414. PubMed ID: 33628745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans Retinoic Acid Augments Autophagy during Intracellular Bacterial Infection.
    Coleman MM; Basdeo SA; Coleman AM; Cheallaigh CN; Peral de Castro C; McLaughlin AM; Dunne PJ; Harris J; Keane J
    Am J Respir Cell Mol Biol; 2018 Nov; 59(5):548-556. PubMed ID: 29852080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.
    Hawn TR; Shah JA; Kalman D
    Immunol Rev; 2015 Mar; 264(1):344-62. PubMed ID: 25703571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing host-pathogen interactions for innovative drug discovery and host-directed therapeutics to tackle tuberculosis.
    Saini S; Gangwar A; Sharma R
    Microbiol Res; 2023 Oct; 275():127466. PubMed ID: 37531813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating Iron for Metabolic Support of TB Host Defense.
    Phelan JJ; Basdeo SA; Tazoll SC; McGivern S; Saborido JR; Keane J
    Front Immunol; 2018; 9():2296. PubMed ID: 30374347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the mTOR Pathway for Tuberculosis Treatment.
    Singh P; Subbian S
    Front Microbiol; 2018; 9():70. PubMed ID: 29441052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
    Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
    Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis.
    Verma RK; Singh AK; Mohan M; Agrawal AK; Verma PR; Gupta A; Misra A
    Mol Pharm; 2012 Nov; 9(11):3183-9. PubMed ID: 22978290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches.
    Mehta K; Spaink HP; Ottenhoff THM; van der Graaf PH; van Hasselt JGC
    Trends Pharmacol Sci; 2022 Apr; 43(4):293-304. PubMed ID: 34916092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loperamide Restricts Intracellular Growth of Mycobacterium tuberculosis in Lung Macrophages.
    Juárez E; Carranza C; Sánchez G; González M; Chávez J; Sarabia C; Torres M; Sada E
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):837-847. PubMed ID: 27468130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Kinase R Restricts the Intracellular Survival of
    Smyth R; Berton S; Rajabalee N; Chan T; Sun J
    Front Microbiol; 2020; 11():613963. PubMed ID: 33552025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
    Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
    Front Immunol; 2020; 11():36. PubMed ID: 32117228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis.
    Bahlool AZ; Fattah S; O'Sullivan A; Cavanagh B; MacLoughlin R; Keane J; O'Sullivan MP; Cryan SA
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flunarizine suppresses Mycobacterium tuberculosis growth via calmodulin-dependent phagosome maturation.
    Mo S; Liu X; Zhang K; Wang W; Cai Y; Ouyang Q; Zhu C; Lin D; Wan H; Li D; Wen Z; Chen X
    J Leukoc Biol; 2022 May; 111(5):1021-1029. PubMed ID: 34533236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of host-directed therapies on the pathology of tuberculosis.
    Tsenova L; Singhal A
    J Pathol; 2020 Apr; 250(5):636-646. PubMed ID: 32108337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Chicoric Acid and 13-Cis Retinoic Acid in Mycobacterium tuberculosis Infection Control by Human U937 Macrophage.
    Abd-Nikfarjam B; Nassiri-Asl M; Hajiaghayi M; Naserpour Farivar T
    Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):399-406. PubMed ID: 29704020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review.
    Kiran D; Basaraba RJ
    Front Cell Infect Microbiol; 2021; 11():624607. PubMed ID: 33718271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.